statistiche ricercatore

MANCINI, NICASIO

Distribuzione geografica

Continente	#
EU - Europa	2.377
NA - Nord America	1.288
AS - Asia	136
OC - Oceania	4
Continente sconosciuto - Info sul continente non disponibili	2
AF - Africa	1
SA - Sud America	1
Totale	3.809

Salva come PNG Salva come JPEG

Nazione	#
IT - Italia	1.910
US - Stati Uniti d'America	1.263
IE - Irlanda	152
UA - Ucraina	84
TR - Turchia	60
SE - Svezia	57
GB - Regno Unito	48
DE - Germania	47
FI - Finlandia	39
CN - Cina	25
VN - Vietnam	24
CA - Canada	23
AT - Austria	13
FR - Francia	12
IN - India	11
HK - Hong Kong	9
CH - Svizzera	5
BE - Belgio	4
SG - Singapore	4
AU - Australia	3
NL - Olanda	3
EU - Europa	2
BR - Brasile	1
CR - Costa Rica	1
ES - Italia	1
IR - Iran	1
JP - Giappone	1
MX - Messico	1
NZ - Nuova Zelanda	1
PH - Filippine	1
PL - Polonia	1
RU - Federazione Russa	1
ZA - Sudafrica	1
Totale	3.809

Salva come PNG Salva come JPEG

Città	#
Milan	1.321
Ashburn	214
Dublin	148
Fairfield	141
Rome	101
Chandler	94
Varese	85
Jacksonville	72
Seattle	71
Woodbridge	55
Como	49
Ogden	49
Houston	46
Wilmington	45
Los Angeles	44
Ann Arbor	41
Washington	41
Nyköping	35
Cambridge	32
Princeton	30
Magnago	26
Izmir	25
Dearborn	23
Toronto	23
San Diego	17
Boardman	14
Vienna	13
West Jordan	12
Pune	11
London	10
Dong Ket	8
Hong Kong	8
Lappeenranta	8
Berlin	7
Hounslow	6
New York	6
Chiswick	5
Frankfurt am Main	5
Kilburn	5
Brussels	4
Nanjing	4
Acton	3
Chicago	3
Norwalk	3
Turin	3
Amsterdam	2
Arezzo	2
Clyde North	2
Desio	2
Hefei	2
Jinan	2
Kunming	2
Lugano	2
Mountain View	2
Naples	2
Paris	2
Pognana Lario	2
Prescot	2
Sarno	2
Southwark	2
Tallahassee	2
Teramo	2
Vedano al Lambro	2
Velletri	2
Verona	2
York	2
Örebro	2
Auckland	1
Bacoor	1
Bouxieres-aux-Dames	1
Castleford	1
Central	1
Cesena	1
Changsha	1
Chengdu	1
Dongguan	1
Düsseldorf	1
Eysines	1
Florence	1
Islington	1
Istanbul	1
Johannesburg	1
Larino	1
Lausanne	1
Limbiate	1
Liverpool	1
Malnate	1
Manchester	1
Melbourne	1
Merate	1
Miami	1
Monterotondo	1
Nanchang	1
Ningbo	1
Pisa	1
Ponte Lambro	1
Rio de Janeiro	1
San José	1
Shanghai	1
Shenyang	1
Totale	3.043

Salva come PNG Salva come JPEG

Nome	#
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques.	141
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).	135
Coronaviridae and SARS-associated coronavirus strain HSR1.	131
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction.	127
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site.	124
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.	121
Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient.	114
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.	93
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021	88
Phage display for the production of human monoclonal antibodies against human pathogens.	86
Humoral immune response against hepatitis C virus.	81
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).	79
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.	76
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?	66
Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy	56
A diet enriched in omega-3 PUFA and inulin prevents type 1 diabetes by restoring gut barrier integrity and immune homeostasis in NOD mice	50
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB	47
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples	44
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells	44
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs	40
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections	38
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine	37
SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital	36
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes	35
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome	35
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review	34
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals	34
Viral respiratory pathogens and lung Injury	34
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools	33
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study	33
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference	33
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020	33
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches	33
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2	32
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?	32
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies	32
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing	32
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)	32
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study	32
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice	31
Risks of "blind" automated identification systems in medical microbiology	31
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes	31
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19	31
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?	31
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses	31
IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2	31
Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies	31
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	30
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death	30
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis	30
Microbiome studies in the medical sciences and the need for closer multidisciplinary interplay	29
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes	29
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases	29
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19	29
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients	29
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens	29
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections	29
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: An IFCC global survey	29
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro	28
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models	28
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein	28
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey	28
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity	28
Interferon-β-1a inhibition of severe acute respiratory syndrome–Coronavirus 2 in vitro when administered after virus infection	28
Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis Virus/HCV pseudotype	28
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients	28
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects	27
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia	27
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine	27
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence	27
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening	27
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro	26
Type III interferons disrupt the lung epithelial barrier upon viral recognition	26
A biologically-validated HCV E1E2 heterodimer structural model	26
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19	25
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	25
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)	25
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects	24
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation	23
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity	22
Answer to photo quiz: Streptococcus pneumoniae	19
The interferon landscape along the respiratory tract impacts the severity of COVID-19	19
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle	18
Role and potential therapeutic use of antibodies against herpetic infections	18
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation	17
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity	17
Lack of efficacy of Interferon β-1a in COVID-19 patients with mild to moderate pneumonia	17
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects	16
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients	16
Dual-domain reporter approach for multiplex identification of major SARS-CoV-2 variants of concern in a microarray-based assay	16
HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role	16
Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence-	16
Monoclonal Antibodies and Flaviviruses: a Possible Option?	16
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy	15
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria	14
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients	14
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols	14
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge	14
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19	14
Evaluation of resistance against bacterial microleakage of a new conical implant-abutment connection versus conventional connections: an in vitro study	14
Totale	3.854

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	26.296
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	26.296

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	90	0	0	0	0	0	0	0	0	0	0	35	55
2019/2020	267	15	9	11	53	16	29	40	34	20	20	2	18
2020/2021	185	3	20	4	22	5	20	18	17	29	6	16	25
2021/2022	219	11	43	20	17	4	0	35	21	16	21	11	20
2022/2023	704	19	7	13	34	34	52	0	39	267	129	35	75
2023/2024	2.651	371	395	336	500	572	254	23	55	79	66	0	0
Totale													4.270